Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New York, New York 10016


Purpose:

Naltrexone is an opioid antagonist with a high affinity for the mu opioid receptor. The efficacy of extended-release naltrexone (Vivitrol) as a treatment for alcohol dependence has been demonstrated in clinical trials, raising the prospect of integrating pharmacologic treatment for alcohol dependence into general medical care settings. However, the feasibility of implementing this FDA approved treatment in the front-line settings in which it is most needed has not been demonstrated. This is an open-label pilot feasibility study of implementing treatment with Vivitrol in primary care medical clinics in a safety net hospital system affiliated with an urban academic center.


Criteria:

Inclusion Criteria: - Current alcohol dependence - Age 18 or older - English or Spanish-speaking - Without untreated severe mental illness - Liver enzymes (ALT and AST) ≤ 3x normal - Kept 2 of last 3 clinic primary care appointments and/or has a working telephone number at which can be contacted directly - Either a) currently abstinent (e.g., referred from an inpatient 'detox' setting) or b) with the ability, in the clinician's judgment, to achieve and maintain abstinence - If female of child-bearing potential, must be using adequate contraception - Able to understand study procedures Exclusion Criteria: - Currently opioid dependent or requiring ongoing treatment with opioids for any indication


NCT ID:

NCT00620750


Primary Contact:

Principal Investigator
Marc N Gourevitch, MD
NYU School of Medicine


Backup Contact:

N/A


Location Contact:

New York, New York 10016
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 17, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.